Bingwen Liu

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Zhiguang Zhou, Min Li, Yufei Xiang, 2020, Journal of Autoimmunity.

The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status

Zhiguang Zhou, Chuqing Cao, Gan Huang, 2017, Journal of diabetes research.

Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy

Ziwei Zhang, S. Luo, Bingwen Liu, 2022, Frontiers in Endocrinology.

Past, present and future of latent autoimmune diabetes in adults

Zhenqi Liu, Zhiguang Zhou, Yufei Xiang, 2020, Diabetes/metabolism research and reviews.

Poor guideline adherence in type 1 diabetes education in real-world clinical practice: Evidence from a multicentre, national survey.

Xilin Yang, Xia Li, Zhiguang Zhou, 2021, Patient education and counseling.

Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial

Xia Li, X. Yan, Zhenqi Liu, 2023, Signal transduction and targeted therapy.

Frequency, clinical features, inflammatory cytokines and genetic background of latent autoimmune diabetes in youth in youth‐onset type 2 diabetes: Results from a nationwide, multicentre, clinic‐based, cross‐sectional study (LADA China)

Xia Li, A. Xu, Lin Yang, 2021, Diabetes, obesity & metabolism.

Association of human leukocyte antigen (HLA) footprints with the comorbidity of latent autoimmune diabetes in adults (LADA) and hepatitis C virus (HCV) infection: A multicenter cross-sectional study.

Zhiguo Xie, Gan Huang, Bingwen Liu, 2023, Diabetes & metabolic syndrome.